Diagnostic chains are expanding laboratories, integrated centres and collection networks as demand grows for preventive, genomics-led and precision testing across India
Triumph will revise ex-showroom prices across its range from January 1, while Renault India will raise prices by up to 2 per cent, urging buyers to lock in current rates
A string of CDSCO approvals and reviews is accelerating India's move to immunotherapies, ADCs and targeted drugs, widening options in major cancers and boosting competition
India's diagnostics sector is seeing a strong shift towards preventive and precision-led testing in 2025, driven by rising demand for proactive health checks and faster genomic diagnostics
Tata Passenger Electric Mobility plans five new EV models by FY30 and Rs 16,000-18,000 crore capex on products, technology and charging infrastructure as Tata EV sales cross 250,000 units
HN Reliance Foundation Hospital has launched a tele-robotic surgery programme, allowing Mumbai surgeons to remotely perform, guide robotic procedures at a Jamnagar partner centre using Jio's network
Cipla has launched Afrezza, an inhaled rapid-acting insulin for adults with diabetes, after CDSCO approval, and plans an awareness drive on insulin adherence
As GLP-1 competition heats up, Emcure is pricing semaglutide brand Poviztra at ₹8,790 a month and targeting demand beyond metros with deeper distribution in smaller cities
Cipla will exclusively market five Pfizer brands in India, adding ₹400-430 crore of established acute therapies to its portfolio without manufacturing risk
Sun Pharma's Baska plant in Gujarat receives OAI status from the US FDA after inspection, adding near-term regulatory uncertainty but not impacting current US supplies
Scheduled for launch in early 2026, the Gravite will be locally manufactured at Renault-Nissan's Chennai plant and is the first model under Nissan's refreshed India strategy
Tata Motors said the new-generation Sierra logged 70,000 confirmed bookings in 24 hours, with deliveries set from January 15, 2026, and prices ranging from Rs 11.49 lakh
This optimistic outlook builds on the fact that Swedish companies invested a total of $2.5 bn in India over the last six years, highlighting the expanding economic corridor between the two nations
The company said the euro-INR exchange rate has stayed above the Rs 100 mark through 2025, well above historical averages, significantly raising its cost base
